Swiss Venture Capital Report 2026 Update (Swiss Venture Capital Report (startupticker))

Summary

• Overall invested capital declined by 15.5% compared to the first half of 2025.p.2
• Capital invested in seed rounds increased by 68.8% to CHF 156 million despite challenging broader conditions.p.7
• Canton Vaud led cantonal rankings with total invested capital of more than CHF 330 million.p.8
• Strategic investments reached 14 deals, doubling the figures recorded in both 2023 and 2024.p.10

Key insights

1. Biotech funding experienced a sharp drop of more than 70% compared to the previous year, securing about CHF 184 million.p.6
2. Companies with all-male management teams received over 88% of total invested capital and closed nearly 79% of funding rounds.p.9
3. LimmaTech Biologics completed a major exit deal, being acquired by Lilly for up to CHF 613 million (USD 780 million).p.10
4. Survey results show rising optimism among investors, with 82% planning to increase their investments over the next 12 months.p.14
5. Confidence in exit prospects improved, with 78% of surveyed investors expecting increased exit opportunities in the coming 12 months.p.14